Literature DB >> 1395192

Recurrent myocardial infarction in a postpartum patient receiving bromocriptine.

F M Eickman1.   

Abstract

Myocardial infarction in puerperium is infrequently reported. Spasm, coronary dissection, or atheromatous etiology has been described. Bromocriptine has been implicated in several previous case reports of myocardial infarction in the puerperium. Our case (including an inadvertent rechallenge) suggests such a relationship. Although generally regarded as "safe," possible serious cardiac effects of bromocriptine should be acknowledged.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1395192     DOI： 10.1002/clc.4960151019

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


  2 in total

Review 1.  A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.

Authors:  J Webster
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

2.  Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.

Authors:  R M Herings; B H Stricker
Journal:  Pharm World Sci       Date:  1995-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.